Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.24
Delayed Data
As of May 01
 +0.29 / +5.86%
Today’s Change
3.10
Today|||52-Week Range
7.84
-30.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line10.4M-35.4M-42.6M4.4M
 
 
 
 
 
Depreciation2.1M1.3M939.0K545.0K
 
 
 
 
 
Total Other Cash Flow6.4M6.2M6.3M7.6M
 
 
 
 
 
Funds From Operations18.8M-27.9M-35.6M11.6M
 
 
 
 
 
Funds From/For Other Operating Expenses422.0K6.7M461.0K-2.2M
 
 
 
 
 
Net Cash Flow - Operating Activities18.4M-34.6M-36.1M13.7M
 
 
 
 
 
 
InvestingDecrease In Investments300.0K100.0K1.1M2.4M
 
 
 
 
 
Capital Expenditures-226.0K-767.0K-137.0K-714.0K
 
 
 
 
 
Fixed Asset Disposal0.00390.0K174.0K143.0K
 
 
 
 
Net Assets From Acquisitions 0.000.001.9M0.00
 
 
Net Cash Flow Investing74.0K-277.0K3.0M1.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.7M23.7M40.1M37.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.0045.0K0.00
 
 
Net Cash Flow - Financing3.7M23.7M40.1M37.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash22.2M-11.3M7.0M53.4M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account